相关实验视频

Updated: Sep 17, 2025

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

细胞特异性载体的临床应用基于糖基化白蛋白

Hitoshi Maeda^1,2

¹Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University.

Biological & pharmaceutical bulletin

|July 2, 2025

概括

曼诺受体以曼诺化人血清白蛋白 (Man-HSA) 作为向的向显示出治疗肝损伤和癌症的前景. 在临床前模型中,新型Man-HSA衍生物有效降低了炎症和瘤生长.

科学领域:

生物医学工程生物医学工程
药物输送系统药物输送系统
免疫学免疫学免疫学

背景情况:

过度活化的巨细胞和纤维细胞会导致肝炎和癌症等疾病.
这些细胞上的曼诺斯受体具有治疗性标.
人类血清中曼诺基化白蛋白 (Man-HSA) 之前被开发用于通过曼诺基受体准库普弗细胞.

研究的目的:

研究Man-HSA用于治疗由巨细胞和纤维细胞驱动的疾病的治疗应用.
开发新的基于Man-HSA的纳米疗法来治疗肝炎和癌症.

主要方法:

开发了SH-Man-HSA (纳米抗氧化剂) 和Man-HSA-interferonα2b (纳米抗炎药),以准库弗弗细胞衍生的氧化应激和炎症.
制造的单聚乙烯甘醇改性Man-HSA (monoPEG-Man-HSA) 作为癌症关联瘤细胞 (TAM-CAF) 的药物递送载体.
在小鼠模型中用帕克利塔塞尔加载的MonoPEG-Man-HSA来评估抑制瘤生长的有效性.

主要成果:

SH-Man-HSA和Man-HSA-IFNα2b减轻了库弗弗细胞介导的损伤,改善了急性和慢性肝炎小鼠模型的生存率.
monoPEG-Man-HSA-paclitaxel通过减少TAM-CAF种群和树叶区域显著抑制瘤生长.
证明了Man-HSA衍生物在向与疾病相关的巨细胞和纤维细胞方面的潜力.

结论:

基于人类HSA的疗法为管理巨细胞和纤维细胞相关疾病提供了一个有希望的策略.
这种方法显示出通过减少肝损伤来治疗肝炎的潜力,并通过向瘤微环境来治疗癌症.
在各种炎症和纤维状疾病中,HSA的固有特性表明它对于创新的药物治疗具有广泛的适用性.

关键词:

专辑蛋白 (albumin) 是一种药物输送系统是药物输送系统.纤维细胞细胞是什么?巨细胞是一个巨细胞.曼诺糖受体的受体为曼诺糖受体.

更多相关视频

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

相关概念视频

Drug Distribution: Plasma Protein Binding

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...

Secondary Active Transport

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...